Donaldson Reports Fourth Quarter and Record Fiscal Year 2023 Sales and Earnings
- Fourth quarter sales declined by 1.2% compared to fiscal 2022.
- Full-year sales increased by 3.8%.
- Fourth quarter and full-year 2023 GAAP EPS were $0.75 and $2.90, respectively.
- Fourth quarter and full-year adjusted EPS were $0.78 and $3.04, respectively.
- Fiscal 2024 sales guidance projects 3% to 7% growth.
- Fiscal 2024 EPS outlook is $3.14 to $3.30.
- None.
Fourth quarter sales declined
Fourth quarter and full-year 2023 GAAP EPS of
Fourth quarter adjusted EPS of
Fiscal 2024 sales guidance of
“Fiscal 2023 was a milestone year as Donaldson delivered record sales and earnings, while also improving margins and investing for future profitable growth,” said Tod Carpenter, chairman, president and chief executive officer. “Our employees demonstrated tremendous resilience and dedication as we redesigned the Company to increase customer focus and efficiency. In the fourth quarter, we continued to strengthen our foundation and made investments in key strategic growth areas, including the Life Sciences segment with our acquisition of Univercells Technologies, to drive Donaldson to the next stage of its evolution.
“We remain focused on executing our balanced growth strategy, strengthening our leadership in legacy markets and expanding across new markets as we provide innovative, technology-led filtration solutions for our customers. While we look to fiscal 2024 as a year of ongoing investments, critical to achieving our long-term financial targets, we are also committed to continuing our best-in-class execution, ongoing R&D initiatives, and the scaling of our acquisitions. As such, we are forecasting another year of record sales, and record earnings and operating margin.”
___________________
1 See Restructuring and Other Charges section for more information.
2 All EPS figures refer to diluted EPS.
3 Adjusted EPS is a non-GAAP financial measure that excludes the impact of certain items not related to ongoing operations.
Fourth Quarter Operating Results
Sales decreased
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
July 31, 2023 |
|
July 31, 2023 |
||||||||
|
Reported %
|
|
Constant
|
|
Reported %
|
|
Constant
|
||||
Mobile Solutions segment |
|
|
|
|
|
|
|
||||
Off-Road |
(0.4 |
)% |
|
(1.3 |
)% |
|
9.8 |
% |
|
14.7 |
% |
On-Road |
5.5 |
|
|
6.4 |
|
|
7.2 |
|
|
11.0 |
|
Aftermarket |
(6.7 |
) |
|
(6.8 |
) |
|
— |
|
|
3.1 |
|
Total Mobile Solutions segment |
(4.8 |
) |
|
(5.0 |
) |
|
2.3 |
|
|
5.7 |
|
|
|
|
|
|
|
|
|
||||
Industrial Solutions segment |
|
|
|
|
|
|
|
||||
Industrial Filtration Solutions |
10.8 |
|
|
10.3 |
|
|
11.7 |
|
|
14.8 |
|
Aerospace and Defense |
4.3 |
|
|
3.0 |
|
|
18.3 |
|
|
20.4 |
|
Total Industrial Solutions segment |
9.9 |
|
|
9.3 |
|
|
12.6 |
|
|
15.6 |
|
|
|
|
|
|
|
|
|
||||
Life Sciences segment |
|
|
|
|
|
|
|
||||
Total Life Sciences segment |
(11.9 |
) |
|
(12.9 |
) |
|
(13.5 |
) |
|
(9.0 |
) |
|
|
|
|
|
|
|
|
||||
Total Company |
(1.2 |
)% |
|
(1.5 |
)% |
|
3.8 |
% |
|
7.2 |
% |
|
|
|
|
|
|
|
|
Mobile Solutions segment (Mobile) sales decreased
Industrial Solutions segment (Industrial) sales increased
Life Sciences segment sales decreased
Gross margin was
Operating expenses as a percentage of sales were
Operating income as a percentage of sales (operating margin) of
Interest expense was
For the full-year, Donaldson paid
Fiscal 2024 Outlook
Full-year EPS is expected to be between
Mobile sales are forecast to increase between
Industrial sales are expected to grow between
Life Sciences sales are forecast to grow approximately
Operating margin is forecast to be between
Interest expense is projected to be approximately
Capital expenditures are forecast to be between
Full-Year Restructuring and Other Charges
During fiscal 2023, Donaldson incurred
During fiscal 2022, in response to the conflict in
Miscellaneous
The Company will webcast its fourth quarter and full-year 2023 earnings conference call today at 9:00 a.m. CT. To listen to the webcast, visit the “Events & Presentations” section of Donaldson’s Investor Relations website (IR.Donaldson.com), and click on the “listen to webcast” option. The webcast replay will be available at approximately 12:00 p.m. CT today. Also available on the website is the Company’s supplemental quarterly earnings presentation.
Statements in this release regarding future events and expectations, such as forecasts, plans, trends and projections relating to the Company’s business and financial performance, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are identified by words or phrases such as “will likely result,” “are expected to,” “will continue,” “will allow,” “estimate,” “project,” “believe,” “expect,” “anticipate,” “forecast,” “plan” and similar expressions. These forward-looking statements speak only as of the date such statements are made and are subject to risks and uncertainties that could affect the Company’s performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed. These factors include, but are not limited to, challenges in global operations; impacts of global economic, industrial and political conditions on product demand, including the
About Donaldson Company, Inc.
Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions, serving a broad range of industries and advanced markets. Diverse, skilled employees at over 140 locations on six continents partner with customers—from small business owners to R&D organizations and the world’s biggest OEM brands. Donaldson solves complex filtration challenges through three primary segments: Mobile Solutions, Industrial Solutions and Life Sciences. Additional information is available at www.Donaldson.com.
DONALDSON COMPANY, INC. AND SUBSIDIARIES |
|||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS |
|||||||||||||||||||||
(In millions, except per share amounts) |
|||||||||||||||||||||
(Unaudited) |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||||||||
|
July 31, |
|
July 31, |
||||||||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
Change |
|
|
2023 |
|
|
|
2022 |
|
|
Change |
||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
$ |
879.5 |
|
|
$ |
890.0 |
|
|
(1.2 |
)% |
|
$ |
3,430.8 |
|
|
$ |
3,306.6 |
|
|
3.8 |
% |
Cost of sales |
|
579.4 |
|
|
|
598.4 |
|
|
(3.2 |
) |
|
|
2,270.2 |
|
|
|
2,239.2 |
|
|
1.4 |
|
Gross profit |
|
300.1 |
|
|
|
291.6 |
|
|
2.9 |
|
|
|
1,160.6 |
|
|
|
1,067.4 |
|
|
8.7 |
|
Selling, general and administrative |
|
157.6 |
|
|
|
143.7 |
|
|
9.7 |
|
|
|
602.3 |
|
|
|
554.8 |
|
|
8.6 |
|
Research and development |
|
22.0 |
|
|
|
18.6 |
|
|
17.9 |
|
|
|
78.1 |
|
|
|
69.1 |
|
|
13.0 |
|
Operating expenses |
|
179.6 |
|
|
|
162.3 |
|
|
10.6 |
|
|
|
680.4 |
|
|
|
623.9 |
|
|
9.1 |
|
Operating income |
|
120.5 |
|
|
|
129.3 |
|
|
(6.8 |
) |
|
|
480.2 |
|
|
|
443.5 |
|
|
8.3 |
|
Interest expense |
|
4.9 |
|
|
|
4.0 |
|
|
20.5 |
|
|
|
19.2 |
|
|
|
14.9 |
|
|
28.9 |
|
Other income, net |
|
(1.7 |
) |
|
|
(3.4 |
) |
|
(50.4 |
) |
|
|
(7.7 |
) |
|
|
(9.8 |
) |
|
(21.0 |
) |
Earnings before income taxes |
|
117.3 |
|
|
|
128.7 |
|
|
(8.8 |
) |
|
|
468.7 |
|
|
|
438.4 |
|
|
6.9 |
|
Income taxes |
|
25.4 |
|
|
|
27.6 |
|
|
(7.9 |
) |
|
|
109.9 |
|
|
|
105.6 |
|
|
4.1 |
|
Net earnings |
$ |
91.9 |
|
|
$ |
101.1 |
|
|
(9.0 |
)% |
|
$ |
358.8 |
|
|
$ |
332.8 |
|
|
7.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average shares – basic |
|
121.4 |
|
|
|
123.0 |
|
|
(1.3 |
)% |
|
|
121.8 |
|
|
|
123.7 |
|
|
(1.5 |
)% |
Weighted average shares – diluted |
|
123.2 |
|
|
|
124.1 |
|
|
(0.7 |
)% |
|
|
123.6 |
|
|
|
125.2 |
|
|
(1.3 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net EPS – basic |
$ |
0.76 |
|
|
$ |
0.82 |
|
|
(7.3 |
)% |
|
$ |
2.95 |
|
|
$ |
2.69 |
|
|
9.7 |
% |
Net EPS – diluted |
$ |
0.75 |
|
|
$ |
0.81 |
|
|
(7.4 |
)% |
|
$ |
2.90 |
|
|
$ |
2.66 |
|
|
9.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Dividends paid per share |
$ |
0.25 |
|
|
$ |
0.23 |
|
|
8.7 |
% |
|
$ |
0.94 |
|
|
$ |
0.89 |
|
|
5.6 |
% |
Note: Amounts may not foot due to rounding. |
DONALDSON COMPANY, INC. AND SUBSIDIARIES |
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(In millions) |
|||||
(Unaudited) |
|||||
|
|
|
|
||
|
July 31, |
|
July 31, |
||
|
2023 |
|
2022 |
||
Assets |
|
|
|
||
Current assets: |
|
|
|
||
Cash and cash equivalents |
$ |
187.1 |
|
$ |
193.3 |
Accounts receivable, net |
|
599.7 |
|
|
616.6 |
Inventories, net |
|
418.1 |
|
|
502.4 |
Prepaid expenses and other current assets |
|
81.1 |
|
|
94.2 |
Total current assets |
|
1,286.0 |
|
|
1,406.5 |
Property, plant and equipment, net |
|
652.9 |
|
|
594.4 |
Goodwill |
|
481.1 |
|
|
345.8 |
Intangible assets, net |
|
188.1 |
|
|
99.8 |
Other long-term assets |
|
162.4 |
|
|
153.8 |
Total assets |
$ |
2,770.5 |
|
$ |
2,600.3 |
|
|
|
|
||
Liabilities and Stockholders’ Equity |
|
|
|
||
Current liabilities: |
|
|
|
||
Short-term borrowings |
$ |
34.1 |
|
$ |
3.7 |
Current maturities of long-term debt |
|
125.0 |
|
|
— |
Accounts payable |
|
304.9 |
|
|
338.5 |
Accrued employee compensation and related taxes |
|
119.4 |
|
|
113.8 |
Deferred revenue |
|
25.3 |
|
|
22.3 |
Income taxes payable |
|
32.3 |
|
|
31.8 |
Dividends payable |
|
30.4 |
|
|
28.3 |
Other current liabilities |
|
85.0 |
|
|
91.2 |
Total current liabilities |
|
756.4 |
|
|
629.6 |
Long-term debt |
|
496.6 |
|
|
644.3 |
Non-current income taxes payable |
|
56.5 |
|
|
69.4 |
Deferred income taxes |
|
32.3 |
|
|
32.7 |
Other long-term liabilities |
|
108.0 |
|
|
91.1 |
Total liabilities |
|
1,449.8 |
|
|
1,467.1 |
|
|
|
|
||
Total stockholders’ equity |
|
1,320.7 |
|
|
1,133.2 |
Total liabilities and stockholders’ equity |
$ |
2,770.5 |
|
$ |
2,600.3 |
DONALDSON COMPANY, INC. AND SUBSIDIARIES |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(In millions) |
|||||||
(Unaudited) |
|||||||
|
|
|
|
||||
|
Twelve Months Ended |
||||||
|
July 31, |
||||||
|
|
2023 |
|
|
|
2022 |
|
Operating Activities |
|
|
|
||||
Net earnings |
$ |
358.8 |
|
|
$ |
332.8 |
|
Adjustments to reconcile net earnings to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
92.3 |
|
|
|
93.8 |
|
Deferred income taxes |
|
(15.3 |
) |
|
|
(1.4 |
) |
Stock-based compensation expense |
|
20.4 |
|
|
|
20.4 |
|
Other, net |
|
6.3 |
|
|
|
10.9 |
|
Changes in operating assets and liabilities |
|
82.0 |
|
|
|
(203.7 |
) |
Net cash provided by operating activities |
|
544.5 |
|
|
|
252.8 |
|
|
|
|
|
||||
Investing Activities |
|
|
|
||||
Purchases of property, plant and equipment |
|
(118.1 |
) |
|
|
(85.1 |
) |
Acquisitions, net of cash acquired |
|
(209.2 |
) |
|
|
(68.9 |
) |
Net cash used in investing activities |
|
(327.3 |
) |
|
|
(154.0 |
) |
|
|
|
|
||||
Financing Activities |
|
|
|
||||
Proceeds from long-term debt |
|
189.2 |
|
|
|
289.3 |
|
Repayments of long-term debt |
|
(219.6 |
) |
|
|
(90.0 |
) |
Change in short-term borrowings |
|
30.4 |
|
|
|
(43.9 |
) |
Purchase of treasury stock |
|
(141.8 |
) |
|
|
(170.6 |
) |
Dividends paid |
|
(114.4 |
) |
|
|
(110.1 |
) |
Tax withholding for stock compensation transactions |
|
(4.3 |
) |
|
|
(1.8 |
) |
Exercise of stock options and other |
|
38.3 |
|
|
|
12.9 |
|
Net cash used in financing activities |
|
(222.2 |
) |
|
|
(114.2 |
) |
Effect of exchange rate changes on cash |
|
(1.2 |
) |
|
|
(14.1 |
) |
Decrease in cash and cash equivalents |
|
(6.2 |
) |
|
|
(29.5 |
) |
Cash and cash equivalents, beginning of year |
|
193.3 |
|
|
|
222.8 |
|
Cash and cash equivalents, end of year |
$ |
187.1 |
|
|
$ |
193.3 |
|
CONSOLIDATED RATE ANALYSIS |
|||||||||||
(Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|
||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
July 31, |
|
July 31, |
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Gross margin |
34.1 |
% |
|
32.8 |
% |
|
33.8 |
% |
|
32.3 |
% |
Operating expenses |
20.4 |
% |
|
18.2 |
% |
|
19.8 |
% |
|
18.9 |
% |
Operating margin |
13.7 |
% |
|
14.5 |
% |
|
14.0 |
% |
|
13.4 |
% |
Other income, net |
(0.2 |
)% |
|
(0.4 |
)% |
|
(0.2 |
)% |
|
(0.3 |
)% |
Depreciation and amortization |
2.9 |
% |
|
2.6 |
% |
|
2.7 |
% |
|
2.8 |
% |
EBITDA |
16.8 |
% |
|
17.5 |
% |
|
16.9 |
% |
|
16.5 |
% |
Effective tax rate |
21.7 |
% |
|
21.4 |
% |
|
23.4 |
% |
|
24.1 |
% |
Earnings before income taxes - Mobile Solutions |
16.2 |
% |
|
15.8 |
% |
|
15.2 |
% |
|
13.8 |
% |
Earnings before income taxes - Industrial Solutions |
19.2 |
% |
|
18.6 |
% |
|
18.4 |
% |
|
14.8 |
% |
Earnings before income taxes - Life Sciences |
(12.4 |
)% |
|
20.3 |
% |
|
4.1 |
% |
|
23.3 |
% |
Cash conversion ratio |
179.9 |
% |
|
79.8 |
% |
|
118.8 |
% |
|
50.4 |
% |
|
|
|
|
|
|
|
|
||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
July 31, |
|
July 31, |
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Adjusted Rates |
|
|
|
|
|
|
|
||||
Gross margin |
34.3 |
% |
|
32.9 |
% |
|
33.9 |
% |
|
32.3 |
% |
Operating expenses |
20.0 |
% |
|
18.0 |
% |
|
19.3 |
% |
|
18.8 |
% |
Operating margin |
14.3 |
% |
|
14.9 |
% |
|
14.6 |
% |
|
13.5 |
% |
Other income, net |
(0.2 |
)% |
|
(0.4 |
)% |
|
(0.2 |
)% |
|
(0.3 |
)% |
Depreciation and amortization |
2.9 |
% |
|
2.6 |
% |
|
2.7 |
% |
|
2.8 |
% |
EBITDA |
17.3 |
% |
|
17.9 |
% |
|
17.5 |
% |
|
16.7 |
% |
Effective tax rate |
21.8 |
% |
|
21.5 |
% |
|
23.5 |
% |
|
24.1 |
% |
Earnings before income taxes - Mobile Solutions |
16.2 |
% |
|
15.8 |
% |
|
15.2 |
% |
|
13.8 |
% |
Earnings before income taxes - Industrial Solutions |
19.2 |
% |
|
18.6 |
% |
|
18.4 |
% |
|
14.8 |
% |
Earnings before income taxes - Life Sciences |
(12.4 |
)% |
|
20.3 |
% |
|
4.1 |
% |
|
23.3 |
% |
Cash conversion ratio |
173.0 |
% |
|
77.8 |
% |
|
113.6 |
% |
|
50.0 |
% |
Note: Rate analysis metrics are computed by dividing the applicable amount by net sales, and cash conversion ratio reflects free cash flow divided by net earnings. Adjusted rates exclude charges related to the organizational redesign and costs associated with exiting a lower-margin customer program in fiscal 2023, and charges related to the conflict in |
SEGMENT DETAIL |
|||||||||||||||||||||
(In millions) |
|||||||||||||||||||||
(Unaudited) |
|||||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
Three Months Ended July 31, |
|
Twelve Months Ended July 31, |
||||||||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
Change |
|
|
2023 |
|
|
|
2022 |
|
|
Change |
||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Off-Road |
$ |
103.4 |
|
|
$ |
103.8 |
|
|
(0.4 |
)% |
|
$ |
428.7 |
|
|
$ |
390.5 |
|
|
9.8 |
% |
On-Road |
|
37.3 |
|
|
|
35.4 |
|
|
5.5 |
|
|
|
145.8 |
|
|
|
136.1 |
|
|
7.2 |
|
Aftermarket |
|
401.8 |
|
|
|
430.9 |
|
|
(6.7 |
) |
|
|
1,600.3 |
|
|
|
1,599.9 |
|
|
— |
|
Total Mobile Solutions segment |
|
542.5 |
|
|
|
570.1 |
|
|
(4.8 |
) |
|
|
2,174.8 |
|
|
|
2,126.5 |
|
|
2.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Industrial Filtration Solutions |
|
241.0 |
|
|
|
217.3 |
|
|
10.8 |
|
|
|
872.2 |
|
|
|
780.5 |
|
|
11.7 |
|
Aerospace and Defense |
|
36.1 |
|
|
|
34.6 |
|
|
4.3 |
|
|
|
142.5 |
|
|
|
120.5 |
|
|
18.3 |
|
Total Industrial Solutions segment |
|
277.1 |
|
|
|
251.9 |
|
|
9.9 |
|
|
|
1,014.7 |
|
|
|
901.0 |
|
|
12.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Life Sciences segment |
|
59.9 |
|
|
|
68.0 |
|
|
(11.9 |
) |
|
|
241.3 |
|
|
|
279.1 |
|
|
(13.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Company |
$ |
879.5 |
|
|
$ |
890.0 |
|
|
(1.2 |
)% |
|
$ |
3,430.8 |
|
|
$ |
3,306.6 |
|
|
3.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Earnings (loss) before income taxes |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Mobile Solutions segment |
$ |
88.1 |
|
|
$ |
89.9 |
|
|
(2.0 |
)% |
|
$ |
330.4 |
|
|
$ |
293.8 |
|
|
12.5 |
% |
Industrial Solutions segment |
|
53.2 |
|
|
|
46.9 |
|
|
13.4 |
|
|
|
186.2 |
|
|
|
133.0 |
|
|
40.0 |
|
Life Sciences segment |
|
(7.4 |
) |
|
|
13.8 |
|
|
(153.6 |
) |
|
|
9.9 |
|
|
|
64.9 |
|
|
(84.7 |
) |
Corporate and unallocated |
|
(16.6 |
) |
|
|
(22.1 |
) |
|
24.9 |
|
|
|
(57.8 |
) |
|
|
(53.3 |
) |
|
(8.4 |
) |
Total Company |
$ |
117.3 |
|
|
$ |
128.5 |
|
|
(8.8 |
)% |
|
$ |
468.7 |
|
|
$ |
438.4 |
|
|
6.9 |
% |
Earnings before income taxes percentage |
|
|
|
|
|
|
|
|
|
|
|
||||||
Mobile Solutions segment |
16.2 |
% |
|
15.8 |
% |
|
0.4 |
% |
|
15.2 |
% |
|
13.8 |
% |
|
1.4 |
% |
Industrial Solutions segment |
19.2 |
% |
|
18.6 |
% |
|
0.6 |
% |
|
18.4 |
% |
|
14.8 |
% |
|
3.6 |
% |
Life Sciences segment |
(12.4 |
)% |
|
20.3 |
% |
|
(32.7 |
)% |
|
4.1 |
% |
|
23.3 |
% |
|
(19.2 |
)% |
Note: Earnings before income taxes percentage is calculated by dividing earnings before income taxes by net sales. Amounts may not foot due to rounding. |
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, AS REPORTED |
||||||||||||||
(Unaudited) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Three Months Ended July 31, 2023 |
|||||||||||||
|
TOTAL |
|
|
|
EMEA(3) |
|
APAC(4) |
|
LATAM (5) |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(0.4 |
)% |
|
(3.2 |
)% |
|
7.4 |
% |
|
(7.9 |
)% |
|
(9.1 |
)% |
On-Road |
5.5 |
|
|
(1.2 |
) |
|
(2.6 |
) |
|
25.9 |
|
|
6.1 |
|
Aftermarket |
(6.7 |
) |
|
(11.2 |
) |
|
9.4 |
|
|
(6.6 |
) |
|
(14.8 |
) |
Total Mobile Solutions segment |
(4.8 |
) |
|
(9.1 |
) |
|
8.4 |
|
|
(4.2 |
) |
|
(14.1 |
) |
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
10.8 |
|
|
9.4 |
|
|
18.4 |
|
|
(2.5 |
) |
|
12.2 |
|
Aerospace and Defense |
4.3 |
|
|
7.1 |
|
|
(0.7 |
) |
|
(8.2 |
) |
|
|
|
Total Industrial Solutions segment |
9.9 |
|
|
9.0 |
|
|
16.1 |
|
|
(2.6 |
) |
|
12.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
(11.9 |
) |
|
37.6 |
|
|
6.4 |
|
|
(39.3 |
) |
|
(7.4 |
) |
|
|
|
|
|
|
|
|
|
|
|||||
Total Company |
(1.2 |
)% |
|
(2.0 |
)% |
|
10.9 |
% |
|
(10.6 |
)% |
|
(11.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|||||
|
Twelve Months Ended July 31, 2023 |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
9.8 |
% |
|
18.2 |
% |
|
9.7 |
% |
|
(4.7 |
)% |
|
26.4 |
% |
On-Road |
7.2 |
|
|
7.7 |
|
|
(1.6 |
) |
|
7.6 |
|
|
29.1 |
|
Aftermarket |
— |
|
|
2.3 |
|
|
(1.2 |
) |
|
(3.8 |
) |
|
0.3 |
|
Total Mobile Solutions segment |
2.3 |
|
|
5.2 |
|
|
1.8 |
|
|
(3.0 |
) |
|
2.0 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
11.7 |
|
|
15.7 |
|
|
10.5 |
|
|
0.8 |
|
|
19.4 |
|
Aerospace and Defense |
18.3 |
|
|
18.5 |
|
|
19.8 |
|
|
(12.3 |
) |
|
|
|
Total Industrial Solutions segment |
12.6 |
|
|
16.2 |
|
|
11.5 |
|
|
0.6 |
|
|
19.4 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
(13.5 |
) |
|
30.3 |
|
|
(0.4 |
) |
|
(34.5 |
) |
|
2.5 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Total Company |
3.8 |
% |
|
9.6 |
% |
|
4.6 |
% |
|
(9.0 |
)% |
|
3.7 |
% |
Note: Amounts may not foot due to rounding.
(1) |
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, CONSTANT CURRENCY |
||||||||||||||
(Unaudited) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Three Months Ended July 31, 2023 |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(1.3 |
)% |
|
(3.2 |
)% |
|
3.0 |
% |
|
(3.5 |
)% |
|
(12.6 |
)% |
On-Road |
6.4 |
|
|
(1.2 |
) |
|
(6.7 |
) |
|
31.7 |
|
|
4.0 |
|
Aftermarket |
(6.8 |
) |
|
(11.2 |
) |
|
6.6 |
|
|
(2.8 |
) |
|
(15.4 |
) |
Total Mobile Solutions segment |
(5.0 |
) |
|
(9.1 |
) |
|
5.1 |
|
|
(0.1 |
) |
|
(14.9 |
) |
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
10.3 |
|
|
9.4 |
|
|
14.9 |
|
|
2.0 |
|
|
11.6 |
|
Aerospace and Defense |
3.0 |
|
|
7.1 |
|
|
(5.1 |
) |
|
(4.7 |
) |
|
|
|
Total Industrial Solutions segment |
9.3 |
|
|
9.0 |
|
|
12.4 |
|
|
1.9 |
|
|
11.6 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
(12.9 |
) |
|
37.6 |
|
|
1.1 |
|
|
(37.5 |
) |
|
(8.6 |
) |
|
|
|
|
|
|
|
|
|
|
|||||
Total Company |
(1.5 |
)% |
|
(2.0 |
)% |
|
7.3 |
% |
|
(6.9 |
)% |
|
(12.6 |
)% |
|
|
|
|
|
|
|
|
|
|
|||||
|
Twelve Months Ended July 31, 2023 |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
14.7 |
% |
|
18.2 |
% |
|
16.2 |
% |
|
5.5 |
% |
|
24.3 |
% |
On-Road |
11.0 |
|
|
7.7 |
|
|
3.3 |
|
|
19.5 |
|
|
27.1 |
|
Aftermarket |
3.1 |
|
|
2.3 |
|
|
5.7 |
|
|
4.0 |
|
|
0.6 |
|
Total Mobile Solutions segment |
5.7 |
|
|
5.2 |
|
|
8.5 |
|
|
5.8 |
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
14.8 |
|
|
15.7 |
|
|
15.7 |
|
|
9.5 |
|
|
19.0 |
|
Aerospace and Defense |
20.4 |
|
|
18.5 |
|
|
26.8 |
|
|
(3.0 |
) |
|
|
|
Total Industrial Solutions segment |
15.6 |
|
|
16.2 |
|
|
16.9 |
|
|
9.3 |
|
|
19.0 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
(9.0 |
) |
|
30.3 |
|
|
5.5 |
|
|
(29.5 |
) |
|
1.8 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Total Company |
7.2 |
% |
|
9.6 |
% |
|
10.8 |
% |
|
(1.0 |
)% |
|
3.7 |
% |
Note: The constant currency presentation, which is a non-GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates. The Company believes providing constant currency information provides valuable supplemental information regarding its results of operations. The Company calculates constant currency percentages by converting its current period local currency financial results using the prior period exchange rates and compares these adjusted amounts to its prior period reported results. Amounts may not foot due to rounding. |
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES |
|||||||||||||||
(In millions, except per share amounts) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
July 31, |
|
July 31, |
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net cash provided by operating activities |
$ |
190.8 |
|
|
$ |
108.9 |
|
|
$ |
544.5 |
|
|
$ |
252.8 |
|
Net capital expenditures |
|
(25.5 |
) |
|
|
(28.3 |
) |
|
|
(118.1 |
) |
|
|
(85.1 |
) |
Free cash flow |
$ |
165.4 |
|
|
$ |
80.6 |
|
|
$ |
426.3 |
|
|
$ |
167.8 |
|
|
|
|
|
|
|
|
|
||||||||
Net earnings |
$ |
91.9 |
|
|
$ |
101.1 |
|
|
$ |
358.8 |
|
|
$ |
332.8 |
|
Income taxes |
|
25.4 |
|
|
|
27.6 |
|
|
|
109.9 |
|
|
|
105.6 |
|
Interest expense |
|
4.9 |
|
|
|
4.0 |
|
|
|
19.2 |
|
|
|
14.9 |
|
Depreciation and amortization |
|
25.1 |
|
|
|
23.0 |
|
|
|
92.3 |
|
|
|
94.0 |
|
EBITDA |
$ |
147.3 |
|
|
$ |
155.7 |
|
|
$ |
580.2 |
|
|
$ |
547.3 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted net earnings |
$ |
95.6 |
|
|
$ |
103.6 |
|
|
$ |
375.2 |
|
|
$ |
335.4 |
|
Adjusted income taxes |
|
26.6 |
|
|
|
28.4 |
|
|
|
115.3 |
|
|
|
106.4 |
|
Interest expense |
|
4.9 |
|
|
|
4.0 |
|
|
|
19.2 |
|
|
|
14.9 |
|
Depreciation and amortization |
|
25.1 |
|
|
|
23.0 |
|
|
|
92.3 |
|
|
|
94.0 |
|
Adjusted EBITDA |
$ |
152.2 |
|
|
$ |
159.0 |
|
|
$ |
602.0 |
|
|
$ |
550.7 |
|
|
|
|
|
|
|
|
|
||||||||
Gross profit |
$ |
300.1 |
|
|
$ |
291.6 |
|
|
$ |
1,160.6 |
|
|
$ |
1,067.4 |
|
Charges related to the conflict in |
|
— |
|
|
|
1.0 |
|
|
|
— |
|
|
|
1.0 |
|
Restructuring and other charges |
|
1.4 |
|
|
|
— |
|
|
|
2.9 |
|
|
|
— |
|
Adjusted gross profit |
$ |
301.5 |
|
|
$ |
292.6 |
|
|
$ |
1,163.5 |
|
|
$ |
1,068.4 |
|
|
|
|
|
|
|
|
|
||||||||
Operating expense |
$ |
179.6 |
|
|
$ |
162.3 |
|
|
$ |
680.4 |
|
|
$ |
623.9 |
|
Charges related to the conflict in |
|
— |
|
|
|
(2.4 |
) |
|
|
— |
|
|
|
(2.4 |
) |
Restructuring and other charges |
|
(3.5 |
) |
|
|
— |
|
|
|
(18.9 |
) |
|
|
— |
|
Adjusted operating expense |
$ |
176.1 |
|
|
$ |
159.9 |
|
|
$ |
661.5 |
|
|
$ |
621.5 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income |
$ |
120.5 |
|
|
$ |
129.3 |
|
|
$ |
480.2 |
|
|
$ |
443.5 |
|
Charges related to the conflict in |
|
— |
|
|
|
3.4 |
|
|
|
— |
|
|
|
3.4 |
|
Restructuring and other charges |
|
4.9 |
|
|
|
— |
|
|
|
21.8 |
|
|
|
— |
|
Adjusted operating income |
$ |
125.4 |
|
|
$ |
132.7 |
|
|
$ |
502.0 |
|
|
$ |
446.9 |
|
|
|
|
|
|
|
|
|
||||||||
Net earnings |
$ |
91.9 |
|
|
$ |
101.1 |
|
|
$ |
358.8 |
|
|
$ |
332.8 |
|
Charges related to the conflict in |
|
— |
|
|
|
2.6 |
|
|
|
— |
|
|
|
2.6 |
|
Restructuring and other charges, net of tax |
|
3.7 |
|
|
|
— |
|
|
|
16.4 |
|
|
|
— |
|
Adjusted net earnings |
$ |
95.6 |
|
|
$ |
103.6 |
|
|
$ |
375.2 |
|
|
$ |
335.4 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted EPS |
$ |
0.75 |
|
|
$ |
0.81 |
|
|
$ |
2.90 |
|
|
$ |
2.66 |
|
Charges per share related to the conflict in |
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.02 |
|
Restructuring and other charges per share |
|
0.03 |
|
|
|
— |
|
|
|
0.14 |
|
|
|
— |
|
Adjusted diluted EPS |
$ |
0.78 |
|
|
$ |
0.84 |
|
|
$ |
3.04 |
|
|
$ |
2.68 |
|
Note: Although free cash flow, EBITDA, adjusted EBITDA, adjusted gross profit, adjusted operating expense, adjusted operating income, adjusted income taxes, adjusted net earnings and adjusted diluted EPS are not measures of financial performance under GAAP, the Company believes they are useful in understanding its financial results. Free cash flow is a commonly used measure of a company’s ability to generate cash in excess of its operating needs. EBITDA is a commonly used measure of operating earnings less non-cash expenses. The adjusted basis presentation excludes the impact of certain matters not related to the Company’s ongoing operations. Management believes that the adjusted basis presentation reflects management’s performance in operating the Company and provides a meaningful representation of the performance of the Company’s core business and is useful to understanding its financial results. A shortcoming of these financial measures is that they do not reflect the Company’s actual results under GAAP. Management does not intend these items to be considered in isolation or as a substitute for the related GAAP measures. Amounts may not foot due to rounding. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230829854257/en/
Sarika Dhadwal (952) 887-3753
Sarika.Dhadwal@Donaldson.com
Source: Donaldson Company, Inc.
FAQ
What were the fourth quarter sales for Donaldson Company, Inc. compared to fiscal 2022?
How much did full-year sales increase by?
What were the GAAP EPS for the fourth quarter and full year of 2023?
What were the adjusted EPS for the fourth quarter and full year of 2023?
What is the sales guidance for fiscal 2024?